Hoa Tran
- Hematology top 5%
- Platelet Disorders and Treatments 8
- Hemophilia Treatment and Research 6
- Hemostasis and retained surgical items 3
- Blood Coagulation and Thrombosis Mechanisms 3
- Acute Myeloid Leukemia Research 2
- Internal Medicine top 10%
-
- Chronic Lymphocytic Leukemia Research 8
-
- Renal cell carcinoma treatment 2
-
- Heparin-Induced Thrombocytopenia and Thrombosis 2
- Co-authors
- Pål André HolmeGeir E. TjønnfjordMats HolmströmStine BjørnsenCarola E. HenrikssonPer Morten SandsetAre Hugo PrippBenny Sørensen
- Partner nations
- NorwayUnited StatesDenmark
In The Last Decade
Hoa Tran
19 papers receiving 236 citations
Peers
Comparison fields: 5 of 32
- Hematology 183
- Internal Medicine 37
- Critical Care and Intensive Care Medicine 26
- Genetics 46
- Biochemistry 11
Countries citing papers authored by Hoa Tran
This map shows the geographic impact of Hoa Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoa Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoa Tran more than expected).
Fields of papers citing papers by Hoa Tran
This network shows the impact of papers produced by Hoa Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoa Tran. The network helps show where Hoa Tran may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hoa Tran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2021 | 10 | |
| 8 | 2020 | 6 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 16 | |
| 11 | 2018 | 2 | |
| 12 | 2017 | 12 | |
| 13 | 2017 | 31 | |
| 14 | 2014 | 29 | |
| 15 | 2013 | 19 | |
| 16 | 2013 | 29 | |
| 17 | 2012 | 51 | |
| 18 | 2012 | 3 | |
| 19 | 2011 | 19 | |
| 20 | 2011 | 6 |
About Hoa Tran
Hoa Tran is a scholar working on Hematology, Genetics, Internal Medicine, Critical Care and Intensive Care Medicine and Immunology, having authored 23 papers that have together received 241 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Platelet Disorders and Treatments (8 papers), Hemophilia Treatment and Research (6 papers), Hemostasis and retained surgical items (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Acute Myeloid Leukemia Research (2 papers), Renal cell carcinoma treatment (2 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). The work is most often cited by research in Hematology (183 citations), Internal Medicine (37 citations), Critical Care and Intensive Care Medicine (26 citations), Genetics (46 citations) and Biochemistry (11 citations). Hoa Tran has collaborated with scholars based in Norway, United States and Denmark. Frequent co-authors include Pål André Holme, Geir E. Tjønnfjord, Mats Holmström, Stine Bjørnsen, Carola E. Henriksson, Per Morten Sandset, Are Hugo Pripp, Benny Sørensen, Nina Haagenrud Schultz and Torill Ueland. Their work appears in journals such as Haemophilia, Blood, Thrombosis Journal, BMJ Open and Research and Practice in Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.